The Loudness Dependence of Auditory Evoked Potentials (LDAEP) in individuals at risk for developing bipolar disorders and schizophrenia

Clinical Neurophysiology

Volumn 127, Issue 2, 2016, Pages 1342-1350

  Hagenmuller, Florence ^a   Heekeren, Karsten ^a   Meier, Magali ^a   Theodoridou, Anastasia ^a   Walitza, Susanne ^a   Haker, Helene ^a   Rössler, Wulf ^a,b   Kawohl, Wolfram ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Bipolar disorders; Dipole source analysis; Primary auditory cortex; Risk; Schizophrenia; Serotonin

Indexed keywords

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BIPOLAR DISORDER; CANNABIS USE; CONTROLLED STUDY; EVOKED AUDITORY RESPONSE; FEMALE; HIGH RISK PATIENT; HUMAN; LOUDNESS DEPENDENCE OF AUDITORY EVOKED POTENTIAL; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; NEUROTRANSMISSION; PRIORITY JOURNAL; SCHIZOPHRENIA; SEROTONINERGIC SYSTEM; ADOLESCENT; AUDITORY CORTEX; AUDITORY EVOKED POTENTIAL; AUDITORY STIMULATION; HEARING; LONGITUDINAL STUDY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; PROSPECTIVE STUDY; RISK FACTOR; YOUNG ADULT;

ACOUSTIC STIMULATION; ADOLESCENT; ADULT; AUDITORY CORTEX; BIPOLAR DISORDER; EVOKED POTENTIALS, AUDITORY; FEMALE; HUMANS; LONGITUDINAL STUDIES; LOUDNESS PERCEPTION; MALE; PROSPECTIVE STUDIES; RISK FACTORS; SCHIZOPHRENIA; YOUNG ADULT;

EID: 84957999104     PISSN: 13882457     EISSN: 18728952     Source Type: Journal    
DOI: 10.1016/j.clinph.2015.10.050     Document Type: Article

References (107)

1. Abi-Dargham A. Alterations of serotonin transmission in schizophrenia. Int Rev Neurobiol 2007, 78:133-164.
2. Addington J., Case N., Saleem M.M., Auther A.M., Cornblatt B.A., Cadenhead K.S. Substance use in clinical high risk for psychosis: a review of the literature. Early Intervension Psychiatry 2013, 8:104-112.
3. Alaerts M., Del-Favero J. Searching genetic risk factors for schizophrenia and bipolar disorder: learn from the past and back to the future. Hum Mutat 2009, 30:1139-1152.
4. Andreasen N.C., Pressler M., Nopoulos P., Miller D., Ho B.-C. Antipsychotic dose equivalents and dose-years: a standardized method for comparing exposure to different drugs. Biol Psychiatry 2010, 67:255-262.
5. Angst J., Adolfsson R., Benazzi F., Gamma A., Hantouche E., Meyer T.D., Skeppar P., Vieta E., Scott J. The HCL-32: towards a self-assessment tool for hypomanic symptoms in outpatients. J Affect Disord 2005, 88:217-233.
6. Ballenger J.C., Goodwin F.K., Major L.F., Brown G.L. Alcohol and central serotonin metabolism in man. Arch Gen Psychiatry 1979, 36:224-227.
7. Baumgarten H.G., Grozdanovic Z. Role of serotonin in obsessive-compulsive disorder. Br J Psychiatry Suppl 1998, 35:13-20.
8. Bechdolf A., Pukrop R., Köhn D., Tschinkel S., Veith V., Schultze-Lutter F., Ruhrmann S., Geyer C., Pohlmann B., Klosterkötter J. Subjective quality of life in subjects at risk for a first episode of psychosis: a comparison with first episode schizophrenia patients and healthy controls. Schizophr Res 2005, 79:137-143.
9. Bechdolf A., Ratheesh A., Cotton S.M., Nelson B., Chanen A.M., Betts J., Bingmann T., Yung A.R., Berk M., McGorry P.D. The predictive validity of bipolar at-risk (prodromal) criteria in help-seeking adolescents and young adults: a prospective study. Bipolar Disord 2014, 16:493-504.
10. Breier A. Serotonin, schizophrenia and antipsychotic drug action. Schizophr Res 1995, 14:187-202.
11. Brietzke E., Mansur R.B., Soczynska J.K., Kapczinski F., Bressan R.A., McIntyre R.S. Towards a multifactorial approach for prediction of bipolar disorder in at risk populations. J Affect Disord 2012, 140:82-91.
12. Brocke B., Beauducel A., John R., Debener S., Heilemann H. Sensation seeking and affective disorders: characteristics in the intensity dependence of acoustic evoked potentials. Neuropsychobiology 2000, 41:24-30.
13. Bruneau N., Roux S., Garreau B., Lelord G. Frontal auditory evoked potentials and augmenting-reducing. Electroencephalogr Clin Neurophysiol Evoked Potentials Sect 1985, 62:364-371.
14. Chen T.J., Yu Y.W., Chen M.C., Wang S.Y., Tsai S.J., Lee T.W. Serotonin dysfunction and suicide attempts in major depressives: an auditory event-related potential study. Neuropsychobiology 2005, 52:28-36.
15. Connor K.M., Davidson J.R.T. Generalized anxiety disorder: neurobiological and pharmacotherapeutic perspectives. Biol Psychiatry 1998, 44:1286-1294.
16. Correll C.U., Hauser M., Auther A.M., Cornblatt B.A. Research in people with psychosis risk syndrome: a review of the current evidence and future directions. J Child Psychol Psychiatry 2010, 51:390-431.
17. Dean B. The cortical serotonin 2A receptor and the pathology of schizophrenia: a likely accomplice. J Neurochem 2003, 85:1-13.
18. Eastwood S.L., Burnet P.W.J., Gittins R., Baker K., Harrison P.J. Expression of serotonin 5-HT2A receptors in the human cerebellum and alterations in schizophrenia. Synapse 2001, 42:104-114.
19. Gallinat J., Bottlender R., Juckel G., Munke-Puchner A., Stotz G., Kuss H.J., Mavrogiorgou P., Hegerl U. The loudness dependency of the auditory evoked N1/P2-component as a predictor of the acute SSRI response in depression. Psychopharmacology 2000, 148:404-411.
20. Grace A.A. Cortical regulation of subcortical dopamine systems and its possible relevance to schizophrenia. J Neural Transm Gen Sect 1993, 91:111-134.
21. Gudlowski Y., Ozgurdal S., Witthaus H., Gallinat J., Hauser M., Winter C., Uhl I., Heinz A., Juckel G. Serotonergic dysfunction in the prodromal, first-episode and chronic course of schizophrenia as assessed by the loudness dependence of auditory evoked activity. Schizophr Res 2009, 109:141-147.
22. Hagenmuller F., Hitz K., Darvas F., Kawohl W. Determination of the loudness dependence of auditory evoked potentials: single-electrode estimation versus dipole source analysis. Hum Psychopharmacol Clin Exp 2011, 26:147-154.
23. Harrison P.J. The neuropathology of schizophrenia. A critical review of the data and their interpretation. Brain 1999, 122:593-624.
24. Harvey I., Persaud R., Ron M.A., Baker G., Murray R.M. Volumetric MRI measurements in bipolars compared with schizophrenics and healthy controls. Psychol Med 1994, 24:689-699.
25. Hegerl U., Gallinat J., Juckel G. Event-related potentials: do they reflect central serotonergic neurotransmission and do they predict clinical response to serotonin agonists?. J Affect Disord 2001, 62:93-100.
26. Hegerl U., Gallinat J., Mrowinski D. Intensity dependence of auditory evoked dipole source activity. Int J Psychophysiol 1994, 17:1-13.
27. Hegerl U., Juckel G. Intensity dependence of auditory evoked potentials as an indicator of central serotonergic neurotransmission: a new hypothesis. Biol Psychiatry 1993, 33:173-187.
28. Hegerl U., Juckel G. Identifying psychiatric patients with serotonergic dysfunctions by event-related potentials. World J Biol Psychiatry 2000, 1:112-118.
29. Heinz A., Bartholomä A., Witthaus H., Forstreuter F., Juckel G. Serotonerge Dysfunktionen bei Patienten mit Alkoholabhängigkeit. Das serotonerge System aus neurologischer und psychiatrischer Sicht 2005, 79-85. Springer. H. Przuntek, T. Müller (Eds.).
30. Hensch T., Herold U., Brocke B. An electrophysiological endophenotype of hypomanic and hyperthymic personality. J Affect Disord 2007, 101:13-26.
31. Hilbert K., Lueken U., Beesdo-Baum K. Neural structures, functioning and connectivity in Generalized Anxiety Disorder and interaction with neuroendocrine systems: a systematic review. J Affect Disord 2014, 158:114-126.
32. Hitz K., Heekeren K., Obermann C., Huber T., Juckel G., Kawohl W. Examination of the effect of acute levodopa administration on the loudness dependence of auditory evoked potentials (LDAEP) in humans. Psychopharmacology 2012, 221:389-396.
33. Howes O.D., Kambeitz J., Kim E., Stahl D., Slifstein M., Abi-Dargham A., Kapur S. The nature of dopamine dysfunction in schizophrenia and what this means for treatment. Arch Gen Psychiatry 2012, 69:776-786.
34. Hurlemann R., Schlaepfer T.E., Matusch A., Reich H., Shah N.J., Zilles K., Maier W., Bauer A. Reduced 5-HT(2A) receptor signaling following selective bilateral amygdala damage. Soc Cogn Affect Neurosci 2009, 4:79-84.
35. Jasper H.H. The ten twenty electrode system of the international federation. Electroencephalogr Clin Neurophysiol 1958, 10:371-375.
36. Juckel G. Serotonin: from sensory processing to schizophrenia using an electrophysiological method. Behav Brain Res 2014, 277:121-124.
37. Juckel G., Gallinat J., Riedel M., Sokullu S., Schulz C., Moller H.J., Muller N., Hegerl U. Serotonergic dysfunction in schizophrenia assessed by the loudness dependence measure of primary auditory cortex evoked activity. Schizophr Res 2003, 64:115-124.
38. Juckel G., Gudlowski Y., Muller D., Ozgurdal S., Brune M., Gallinat J., Frodl T., Witthaus H., Uhl I., Wutzler A., Pogarell O., Mulert C., Hegerl U., Meisenzahl E.M. Loudness dependence of the auditory evoked N1/P2 component as an indicator of serotonergic dysfunction in patients with schizophrenia - a replication study. Psychiatry Res 2008, 158:79-82.
39. Juckel G., Hegerl U., Molnar M., Csepe V., Karmos G. Auditory evoked potentials reflect serotonergic neuronal activity - a study in behaving cats administered drugs acting on 5-HT1A autoreceptors in the dorsal raphe nucleus. Neuropsychopharmacology 1999, 21:710-716.
40. Juckel G., Kawohl W., Giegling I., Mavrogiorgou P., Winter C., Pogarell O., Mulert C., Hegerl U., Rujescu D. Association of catechol-O-methyltransferase variants with loudness dependence of auditory evoked potentials. Hum Psychopharmacol 2008, 23:115-120.
41. Juckel G., Pogarell O., Augustin H., Mulert C., Muller-Siecheneder F., Frodl T., Mavrogiorgou P., Hegerl U. Differential prediction of first clinical response to serotonergic and noradrenergic antidepressants using the loudness dependence of auditory evoked potentials in patients with major depressive disorder. J Clin Psychiatry 2007, 68:1206-1212.
42. Kasai K., Iwanami A., Yamasue H., Kuroki N., Nakagome K., Fukuda M. Neuroanatomy and neurophysiology in schizophrenia. Neurosci Res 2002, 43:93-110.
43. Kawohl W., Giegling I., Mavrogiorgou P., Pogarell O., Mulert C., Moller H.J., Hegerl U., Rujescu D., Juckel G. Association of functional polymorphisms in NOS1 and NOS3 with loudness dependence of auditory evoked potentials. Int J Neuropsychopharmacol 2008, 11:477-483.
44. Kawohl W., Hegerl U., Muller-Oerlinghausen B., Juckel G. Insights in the central serotonergic function in patients with affective disorders. Neuropsychiatry 2008, 22:23-27.
45. Kempton M.J., Geddes J.R., Ettinger U., Williams S.C., Grasby P.M. Meta-analysis, database, and meta-regression of 98 structural imaging studies in bipolar disorder. Arch Gen Psychiatry 2008, 65:1017-1032.
46. Kenemans J.L., Kähköhnen S. How human electrophysiology informs psychopharmacology: from bottom-up driven processing to top-down control. Neuropsychopharmacology 2011, 36:26-51.
47. Kim D.-H., Park Y.-M. The association between suicidality and serotonergic dysfunction in depressed patients. J Affect Disord 2013, 148:72-76.
48. Knight R.T., Scabini D., Woods D.L. Prefrontal cortex gating of auditory transmission in humans. Brain Res 1989, 504:338-342.
49. Kurnianingsih Y.A., Kuswanto C.N., McIntyre R.S., Qiu A., Ho B.C., Sim K. Neurocognitive-genetic and neuroimaging-genetic research paradigms in schizophrenia and bipolar disorder. J Neural Transm 2011, 118:1621-1639.
50. Larson M.K., Walker E.F., Compton M.T. Early signs, diagnosis and therapeutics of the prodromal phase of schizophrenia and related psychotic disorders. Expert Rev Neurother 2011, 10:1347-1359.
51. Lee K.S., Park Y.M., Lee S.H. Serotonergic dysfunction in patients with bipolar disorder assessed by the loudness dependence of the auditory evoked potential. Psychiatry Invest 2012, 9:298-306.
52. Lee T.W., Yu Y.W., Chen T.J., Tsai S.J. Loudness dependence of the auditory evoked potential and response to antidepressants in Chinese patients with major depression. J Psychiatry Neurosci 2005, 30:202-205.
53. Linka T., Müller B.W., Bender S., Sartory G. The intensity dependence of the auditory evoked N1 component as a predictor of response to Citalopram treatment in patients with major depression. Neurosci Lett 2004, 367:375-378.
54. Linka T., Sartory G., Bender S., Gastpar M., Muller B.W. The intensity dependence of auditory ERP components in unmedicated patients with major depression and healthy controls. An analysis of group differences. J Affect Disord 2007, 103:139-145.
55. Linka T., Sartory G., Gastpar M., Scherbaum N., Muller B.W. Clinical symptoms of major depression are associated with the intensity dependence of auditory event-related potential components. Psychiatry Res 2009, 169:139-143.
56. Lish J.D., Dime-Meenan S., Whybrow P.C., Price R.A., Hirschfeld R. The National Depressive and Manic-depressive Association (DMDA) survey of bipolar members. J Affect Disord 1994, 31:281-294.
57. Mahmood T., Silverstone T. Serotonin and bipolar disorder. J Affect Disord 2001, 66:1-11.
58. McBride P.A., Tierney H., DeMeo M., Chen J.-S., Mann J.J. Effects of age and gender on CNS serotonergic responsivity in normal adults. Biol Psychiatry 1990, 27:1143-1155.
59. McGlashan T.H., Miller T.J., Woods S.W., Rosen J.L., Hoffman R.E., Davidson L. Structured interview for prodromal syndromes 2001, PRIME Research Clinic, Yale School of Medicine, New Haven, CT.
60. Meltzer H.Y., Fatemi S.H. The role of serotonin in schizophrenia and the mechanism of action of antipsychotic drugs. Antipsychotic treatment 1996, 77-107. Marcel Decker, New York. J.M. Kane, H.-J. Möller, F. Awouters (Eds.).
61. Meltzer H.Y., Massey B.W. The role of serotonin receptors in the action of atypical antipsychotic drugs. Curr Opin Pharmacol 2011, 11:59-67.
62. Miller G.A., Chapman J.P. Misunderstanding analysis of covariance. J Abnorm Psychol 2001, 110:40-48.
63. Murray R.M., Sham P., Van Os J., Zanelli J., Cannon M., McDonald C. A developmental model for similarities and dissimilarities between schizophrenia and bipolar disorder. Schizophr Res 2004, 71:405-416.
64. Ngan E.T.C., Yatham L.N., Ruth T.J., Liddle P.F. Decreased serotonin 2A receptor densities in neuroleptic-naive patients with schizophrenia: a PET study using [18F] setoperone. Am J Psychiatry 2000, 157:1016-1018.
65. O'Neill B.V., Croft R.J., Nathan P.J. The loudness dependence of the auditory evoked potential (LDAEP) as an in vivo biomarker of central serotonergic function in humans: rationale, evaluation and review of findings. Hum Psychopharmacol Clin Exp 2008, 23:355-370.
66. O'Neill B.V., Croft R.J., Leung S., Guille V., Galloway M., Phan K., Nathan P.J. Dopamine receptor stimulation does not modulate the loudness dependence of the auditory evoked potential in humans. Psychopharmacology 2006, 188:92-99.
67. Ollat H., Parvez H., Parvez S. Alcohol and central neurotransmission. Neurochem Int 1988, 13:275-300.
68. Ostermann J., Uhl I., Kohler E., Juckel G., Norra C. The loudness dependence of auditory evoked potentials and effects of psychopathology and psychopharmacotherapy in psychiatric inpatients. Hum Psychopharmacol 2012, 27:595-604.
69. Paige S.R., Fitzpatrick D.F., Kline J.P., Balogh S.E., Hendricks S.E. Event-related potential amplitude/intensity slopes predict response to antidepressants. Neuropsychobiology 1994, 30:197-201.
70. Pantelis C., Yücel M., Wood S.J., McGorry P.D., Velakoulis D. Early and late neurodevelopmental disturbances in schizophrenia and their functional consequences. Aust N Z J Psychiatry 2003, 37:399-406.
71. Park Y.-M., Kim D.-W., Kim S., Im C.-H., Lee S.-H. The loudness dependence of the auditory evoked potential (LDAEP) as a predictor of the response to escitalopram in patients with generalized anxiety disorder. Psychopharmacology 2011, 213:625-632.
72. Park Y.-M., Lee B.-H., Lee S.-H. The association between serum lipid levels, suicide ideation, and central serotonergic activity in patients with major depressive disorder. J Affect Disord 2014, 159:62-65.
73. Park Y.M., Lee S.H., Kim S., Bae S.M. The loudness dependence of the auditory evoked potential (LDAEP) in schizophrenia, bipolar disorder, major depressive disorder, anxiety disorder, and healthy controls. Progr Neuropsychopharmacol Biol Psychiatry 2010, 34:313-316.
74. Perlis R.H., Miyahara S., Marangell L.B., Wisniewski S.R., Ostacher M., DelBello M.P., Bowden C.L., Sachs G.S., Nierenberg A.A. Long-term implications of early onset in bipolar disorder: data from the first 1000 participants in the systematic treatment enhancement program for bipolar disorder (STEP-BD). Biol Psychiatry 2004, 55:875-881.
75. Pogarell O., Tatsch K., Juckel G., Hamann C., Mulert C., Popperl G., Folkerts M., Chouker M., Riedel M., Zaudig M., Moller H.J., Hegerl U. Serotonin and dopamine transporter availabilities correlate with the loudness dependence of auditory evoked potentials in patients with obsessive-compulsive disorder. Neuropsychopharmacology 2004, 29:1910-1917.
76. Preuss U.W., Bondy B., Zill P., Frodl T., Soyka M., Möller H.J., Hegerl U. Possible association between loudness dependence of auditory evoked potentials and tryptophan hydroxylase-alleles in alcoholics. Addict Biol 2000, 5:297-305.
77. Redpath H.L., Cooper D., Lawrie S.M. Imaging symptoms and syndromes: similarities and differences between schizophrenia and bipolar disorder. Biol Psychiatry 2013, 73:495-496.
78. Roser P., Della B., Norra C., Juckel G., Uhl I. No association between chronic cannabis use and loudness dependence of auditory evoked potentials as indicator of central serotonergic neurotransmission. Neurosci Lett 2009, 465:113-117.
79. Ruhrmann S., Paruch J., Bechdolf A., Pukrop R., Wagner M., Berning J., Schultze-Lutter F., Janssen B., Gaebel W., Möller H.-J. Reduced subjective quality of life in persons at risk for psychosis. Acta Psychiatr Scand 2008, 117:357-368.
80. Scherg M. Fundamentals of dipole source potential analysis. Auditory evoked magnetic fields and electric potentials. Adv Audiol 1990, 6:40-69.
81. Schultze-Lutter D.-P.F., Picker H., Ruhrmann S., Klosterkötter J. Das Köllner Früh-Erkennungs- & Therapie-Zentrum für psychische Krisen (FETZ). Med Klin 2008, 103:81-89.
82. Schultze-Lutter F. Subjective symptoms of schizophrenia in research and the clinic: the basic symptom concept. Schizophr Bull 2009, 35:5-8.
83. Schultze-Lutter F., Addington J., Ruhrmann S., Klosterkötter J. Schizophrenia proneness instrument, adult version (SPI-A) 2007, Giovanni Fioriti, Rome.
84. Schultze-Lutter F., Koch E. Schizophrenia pronennes instrument, child & youth version (SPI-CY) 2010, Giovanni Fioriti, Rome.
85. Schultze-Lutter F., Ruhrmann S., Picker H., von Reventlow H.G., Brockhaus-Dumke A., Klosterkötter J. Basic symptoms in early psychotic and depressive disorders. Br J Psychiatry 2007, 191:31-37.
86. Sellers E.M., Higgins G.A., Sobell M.B. 5-HT and alcohol abuse. Trends Pharmacol Sci 1992, 13:69-75.
87. Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P., Janavs J., Weiller E., Hergueta T., Baker R., Dunbar G.C. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998, 59(Suppl. 20):22-33. quiz 34-57.
88. Shiah I.S., Yatham L.N. Serotonin in mania and in the mechanism of action of mood stabilizers: a review of clinical studies. Bipolar Disord 2000, 2:77-92.
89. Stein D.J. Obsessive-compulsive disorder. The Lancet 2002, 360:397-405.
90. Stephan K.E., Friston K.J., Frith C.D. Dysconnection in schizophrenia: from abnormal synaptic plasticity to failures of self-monitoring. Schizophr Bull 2009, 35:509-527.
91. Strauss J.S., Carpenter W.T., Bartko J.J. Speculations on the processes that underlie schizophrenic symptoms and signs: III. Schizophr Bull 1974, 1:61.
92. Tauscher J., Verhoeff N.P., Christensen B.K., Hussey D., Meyer J.H., Kecojevic A., Javanmard M., Kasper S., Kapur S. Serotonin 5-HT1A receptor binding potential declines with age as measured by [11C]WAY-100635 and PET. Neuropsychopharmacology 2001, 24:522-530.
93. Thaker G. Psychosis endophenotypes in schizophrenia and bipolar disorder. Schizophr Bull 2008, 34:720-721.
94. Theodoridou A., Heekeren K., Dvorsky D., Metzler S., Franscini M., Haker H., Kawohl W., Rüsch N., Walitza S., Rössler W. Early recognition of high risk of bipolar disorder and psychosis: an overview of the ZInEP "Early Recognition" study. Front Public Health 2014, 2:166.
95. Tuchtenhagen F., Daumann J., Norra C., Gobbele R., Becker S., Pelz S., Sass H., Buchner H., Gouzoulis-Mayfrank E. High intensity dependence of auditory evoked dipole source activity indicates decreased serotonergic activity in abstinent ecstasy (MDMA) users. Neuropsychopharmacology 2000, 22:608-617.
96. van Os J. The many continua of psychosis. JAMA psychiatry 2014, 71:985-986.
97. van Veelen N.M., Kahn R.S. Dopamine, serotonin, and schizophrenia. Adv Neurol 1999, 80:425-429.
98. Whalley H.C., Papmeyer M., Sprooten E., Lawrie S.M., Sussmann J.E., McIntosh A.M. Review of functional magnetic resonance imaging studies comparing bipolar disorder and schizophrenia. Bipolar Disord 2012, 14:411-431.
99. Williams J.B. A structured interview guide for the Hamilton Depression Rating Scale. Arch Gen Psychiatry 1988, 45:742-747.
100. Wotruba D., Michels L., Buechler R., Metzler S., Theodoridou A., Gerstenberg M., Walitza S., Kollias S., Rossler W., Heekeren K. Aberrant coupling within and across the default mode, task-positive, and salience network in subjects at risk for psychosis. Schizophr Bull 2014, 40:1095-1104.
101. Wright I.C., Rabe-Hesketh S., Woodruff P.W.R., David A.S., Murray R.M., Bullmore E.T. Meta-analysis of regional brain volumes in schizophrenia. Am J Psychiatry 2000, 157:16-25.
102. Wyss C., Boers F., Kawohl W., Arrubla J., Vahedipour K., Dammers J., Neuner I., Shah N.J. Spatiotemporal properties of auditory intensity processing in multisensor MEG. NeuroImage 2014, 102(Part 2):465-473.
103. Wyss C., Hitz K., Hengartner M.P., Theodoridou A., Obermann C., Uhl I., Roser P., Grunblatt E., Seifritz E., Juckel G., Kawohl W. The loudness dependence of auditory evoked potentials (LDAEP) as an indicator of serotonergic dysfunction in patients with predominant schizophrenic negative symptoms. PLoS ONE 2013, 8:e68650.
104. Yamaguchi S., Knight R.T. Gating of somatosensory input by human prefrontal cortex. Brain Res 1990, 521:281-288.
105. Yung A.R., McGorry P.D., McFarlane C.A., Jackson H.J., Patton G.C., Rakkar A. Monitoring and care of young people at incipient risk of psychosis. Schizophr Bull 1996, 22:283-303.
106. Yung A.R., Yuen H.P., McGorry P.D., Phillips L.J., Kelly D., Dell'Olio M., Francey S.M., Cosgrave E.M., Killackey E., Stanford C. Mapping the onset of psychosis: the Comprehensive Assessment of At-Risk Mental States. Aust N Z J Psychiatry 2005, 39:964-971.
107. Zavos H.M., Freeman D., Haworth C.M., McGuire P., Plomin R., Cardno A.G., et al. Consistent etiology of severe, frequent psychotic experiences and milder, less frequent manifestations: a twin study of specific psychotic experiences in adolescence. JAMA Psychiatry 2014, 71:1049-1057.